The potential and challenges of mucosal COVID-19 vaccines
NIH, National Institute of Allergy and Infectious Diseases (NIAID)In November 2022, the National Institute of Allergy and Infectious Diseases (NIAID) co-hosted a virtual workshop on the importance and challenges of developing mucosal vaccines for SARS-COV-2. The highlights of this workshop have now been published as a report in npj Vaccines.